AzTrials
AzTrials

Mobile Phone UseIn-the-kNOWNCT05080972

Mobile HIV Prevention App for Black Women

A study testing in-the-kNOW mobile app in people with Mobile Phone Use and Hiv, run by Emory University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Black women have a significantly higher risk of acquiring HIV compared to their non-Black counterparts. The purpose of this study is to refine and test a mobile HIV Prevention and Reproductive Health app developed specifically for Black women. Read more about this study

Who is it for?
Ages 18 to 44 years, women onlyHealthy volunteers can take part
Conditions the study is for
Mobile Phone Use, Hiv, Stigma, Social
What is being tested?
in-the-kNOW mobile app
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteUnited States
Study dates
5 Feb 2022to 31 Dec 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 44 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-44 years of age
  • Self-identify as Black
  • Assigned female at birth and identify as female
  • Individuals who qualify for Pre-Exposure Prophylaxis (PrEP) based on the Centers for Disease Control (CDC) criteria (for residence in high HIV incidence areas-reside in Fulton, Cobb, Gwinnett, or Dekalb counties)
  • Sexually active within the last 6 months
  • HIV-negative
  • Owner of an Android or IOS smartphone

Who cannot join

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Cognitively impaired or Individuals with Impaired Decision-Making Capacity
  • Individuals who are not able to clearly understand English

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Center for Black Women's Wellness

    Atlanta, Georgia, 30312

Other trials in United States

About this study

Official title: In-the-kNOW (Novel Approaches to Optimizing Women's Health): A Mobile Application to Optimize HIV Prevention and Sexual/Reproductive Health Communication Among Black Women in the Southern U.S.

Black women have a significantly higher risk of acquiring HIV compared to their non-Black counterparts.

The purpose of this study is to refine and test a mobile HIV Prevention and Reproductive Health app developed specifically for Black women.

Read the detailed description

The overall goal in implementing this study will be to assess the feasibility, acceptability, and usability of the in-the-kNOW mobile app. The app will be refined using preliminary data obtained through prior research with Black women in which their perspectives towards the use of an HIV and sexual health mobile app were ascertained.

Preliminary data obtained from a Community Advisory Board (CAB), which will consist predominately of Black women will guide refinement of the content and features included within the mobile app, whilst ensuring that the app is tailored towards the needs and perspectives of Black women.

This will be a randomized study with quantitative data collected through surveys, and qualitative data collected through in-depth interviews.

Being tested
in-the-kNOW mobile app, Control
Medical subject headings
Cell Phone Use, Acquired Immunodeficiency Syndrome, Social Stigma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • in-the-kNOW mobile appBehavioural

    Also called in-the-kNOW mobile health app

    in-the-kNOW is a mobile app with restricted access through a single-use registration code.

    The app will be developed with regular input from Black women enrolled in Atlanta Healthy Start Initiative (AHSI).

    The app will have culturally- and contextually targeted HIV prevention and optimal sexual health messaging.

    Each participant will have 4 months to engage with the app, with e-reminders in time intervals preferred by the participants (a minimum of 3 times per week) via push notifications. During the 4-month study period, participants will receive push notifications to encourage the use of all app domains: My Logger, My Test, My Resources, and My Circle.

    Research staff will complete 2-month check-ins via phone call or video chat with participants.

  • ControlBehavioural

    Also called Regular Care

    The control condition will be a one-time virtual women's health counseling session with a healthcare provider. Participants will get information on

    1. Sexual Transmitted Infections (STI)/HIV prevention,
    2. Family planning, and
    3. General health promotion (e.g., exercise and diet).

    The control condition provides access to HIV prevention materials that are publicly available but that do not offer the dynamic and individually customized features of the health communication/new media research approach proposed herein.

    Control group participants will continue to receive the usual care associated with Atlanta Healthy Start Initiative (AHSI) enrollment.

    The control group will not have access to intervention content (e.g. commodity ordering) until after the study has concluded.

    Research staff will complete 2-month check-ins via phone call or video chat with participants.

Study groups in NCT05080972
Study groupRoleWhat they receive
in-the-kNOW mobile app.ExperimentalParticipants will be assigned to the in-the-kNOW mobile app for four (4) months.
Receives: Behavioral: in-the-kNOW mobile app
Control condition.Active comparatorParticipants will be randomized to receive a one-time virtual women's health counseling session with a healthcare provider.
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Retention Rate

    Feasibility is assessed with the retention rate of participants in each study arm. Quantitative survey and qualitative interview data to determine acceptability of both the mobile app and the control condition.

    Measured: 4 months

  2. App User Retention Rate

    App user retention rate was calculated among participants only in the intervention group. App user retention was measured by comparing the number of first-time app opens to the number of app removals.

    Measured: 4 months

  3. System Usability Scale (SUS)

    The System Usability Scale (SUS) is a validated industry-standard scale used to evaluate a variety of products and services, including websites, mobile phones, computer software, and more. It is a quick, 10-item questionnaire for gauging perceived usability, resulting in a score from 0-100, where higher is better, with 68 as the average benchmark, and scores above 80 considered excellent; it's calculated by summing adjusted responses to positive/negative statements. Lower scores indicate low usability, and higher scores indicate good usability.

    *Only participants in the treatment group received these questions.

    Measured: 4 months

  4. Impact Scale

    Impact is evaluated using three items that assess how the SavvyHER app influences Black women's quality of life and their sexual and reproductive health. Items prompt participants to rate their agreement with statements such as "I think SavvyHER will be a positive addition to sexual and reproductive health resources for Black women" and "I think SavvyHER will improve the Quality of Life for Black women," with responses on a scale from "strongly disagree" (1) to "strongly agree" (5). Scores were calculated by averaging the responses. Impact scores ranged from 1 to 5, where 1 indicates the least perceived impact, and 5 indicates the most positive perceived impact. A high impact score indicates that the users perceive the technology as having a strong, positive, real-world effect on their relevant outcomes or performance.

    Higher scores indicate that the mHealth app had a more positive impact on their quality of life and health.

    Measured: 4 months

  5. Perceived Usefulness (PU) Scale

    Perceived usefulness (PU) is defined as the extent to which a person believes that using a system or tool will help in reaching their goals. The PU of SavvyHER was determined from participants' responses to nine survey items assessing the app's impact on their quality of life and health management. Survey items used 5-point Likert scales, ranging from "strongly disagree" (1) to "strongly agree" (5). These scores are calculated by averaging the responses across PU items. PU scores ranged from 1 to 5, with higher scores indicating a more positive perception of the technology being evaluated.

    Measured: 4 months

  6. Perceived Ease of Use (PEOU) Scale

    Perceived ease of use (PEOU) is the extent to which a system or tool is easy to learn and use.

    PEOU is assessed using five survey items rated on a 5-point Likert scale that ask about people's experiences learning to operate a technological system or tool. Sample items prompt participants to rate their agreement with statements such as "Learning to operate SavvyHER is easy for me" and "It is easy for me to become skillful at using SavvyHER," with responses on a scale from "strongly disagree" (1) to "strongly agree" (5). Scores were calculated by averaging responses across PEOU items. PEOU scores ranged from 1 to 5, with higher scores indicating that users find the system intuitive. A high PEOU score suggests that users find the system intuitive.

    Measured: 4 months

Secondary outcomes (6)
  1. Number of Home Test Kits Ordered by Participants.

    The research team will measure HIV testing by counting the number of home test kits ordered by participants and receiving HIV test results from TBD Health. TBD Health partnered with the research team on at-home testing, laboratory work, and linking participants to care. Only participants in the treatment arm had access to at-home HIV testing; control participants did not.

    Measured: 4 months

  2. Number of Participants Indicating Intention to Start PrEP

    Participants were asked about their intention to initiate PrEP during the 4-month study period using a post-test survey. Intention was assessed through a series of statements rated on a 5-point Likert scale (from 'definitely not' to 'definitely'

    Measured: 4 months

  3. Number of Participants Who Agreed With Statements About PrEP Initiation

    Participants were asked to select the statement that best reflected their attitude toward initiating PrEP from a predefined list of options.

    Measured: 4 months

  4. Number of Participant's Who Initiated PrEP Treatment

    The research team asked participants about their PrEP initiation. Response options were yes/no if participants had started PrEP by the end of the study period.

    Measured: 4 months

  5. Number of Enrolled Participants by Recruiting Source

    Enrolled participants were asked how they heard about the study, allowing researchers to determine which method yielded the largest number of enrolled individuals.

    Measured: 4 months

  6. Number of Participants Reporting Smartphone Ownership

    Participants who owned/used their smartphones for the intervention.

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2021
  2. Study start5 Feb 2022
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05080972
Sponsor's protocol ID
STUDY00002857
Other IDs
1R34MH128048-01, 2024P007523
Acronym
In-the-kNOW
Status last verified
Feb 2026
First submitted
22 Sep 2021
Last updated
16 Mar 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Questions about this trial

What is this clinical trial studying?

A study testing in-the-kNOW mobile app in people with Mobile Phone Use and Hiv, run by Emory University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 16 Mar 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Retention Rate (time frame: 4 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in